SCHEMBL2973996

SCHEMBL2973996

Cc1cc(C)c(-c2c(Br)cc3c(c2C)C=CC3)c(C)c1

nearest known ligand 0.31

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
MAPT P10636 1/20 0.31
KMT2A Q03164 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2962614 0.79 MEN1 (0.31) MEN1ALDH1A1MAPTKMT2ASMN1; SMN2
SCHEMBL2969303 0.79 MEN1 (0.33) MEN1ALDH1A1MAPTKMT2ASMN1; SMN2
SCHEMBL2973195 0.79 MEN1 (0.35) MEN1ALDH1A1MAPTKMT2ASMN1; SMN2
SCHEMBL2958415 0.77 MEN1 (0.37) MEN1ALDH1A1MAPTKMT2ASMN1; SMN2
SCHEMBL2969305 0.77 CD274 (0.34) ALDH1A1
SCHEMBL2974827 0.77
SCHEMBL2969947 0.76 MEN1 (0.31) MEN1ALDH1A1MAPTKMT2ASMN1; SMN2
SCHEMBL2973424 0.76 CYP1A1 (0.33) MEN1KMT2A
SCHEMBL2959691 0.76 MAOA (0.32)
SCHEMBL2963512 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7763562-B2 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2010-07-27 US disclosed
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2007-06-14 US disclosed
WO-2006065809-A2 HETEROATOM BRIDGED METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2006-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization AP2M1, AP1M1, PYM1 MEN1 750/4885ALDH1A1 4332/4885MAPT 206/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.